Josephine De Vliegher 1 – 3 of 3 publications Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Download search results Subscribe to news feed Add to list Journal Article A1 open access One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer Jonas Steenbrugge (UGent) , Julie Bellemans (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Josephine De Vliegher, Timothy Perera, Olivier De Wever (UGent) , Wim Van Den Broeck (UGent) , Ward De Spiegelaere (UGent) , Niek Sanders (UGent) , et al. (2022) ONCOIMMUNOLOGY. 11(1). Add to list Conference Paper C3 Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent) (2021) OncoDot.3 symposium, Abstracts. Add to list Conference Paper C3 Immunomodulation by cisplatin chemotherapy in an immunocompetent intraductal model for triple-negative breast cancer Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent) (2021) 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Abstracts.
